Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8974801
APP PUB NO 20080153784A1
SERIAL NO

11768181

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Pharmaceutical compositions for long-term sustained release of bisphosphonate drugs are provided. In one embodiment, the composition includes an aqueous suspension of a solid which includes a salt of a bisphosphonate drug and a salt of pentavalent phosphorus oxoacid. The compositions can be used to treat a variety of bone diseases, including osteoporosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
AMPHASTAR PHARMACEUTICALS INC11570 6TH STREET RANCHO CUCAMONGA CA 91730-6025

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ding, Jie Fei Riverside, US 15 58
Fei, Dingyuan Montclair, US 3 15
Luo, Mary Ziping Diamond Bar, US 17 343
Xie, Kevin Anaheim, US 21 96
Zhang, Jack Yongfeng Diamond Bar, US 29 286

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 10, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00